These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9402149)

  • 1. In pursuit of drugs for American trypanosomiasis: evaluation of some "standards" in a mouse model.
    Kinnamon KE; Poon BT; Hanson WL; Waits VB
    Proc Soc Exp Biol Med; 1997 Dec; 216(3):424-8. PubMed ID: 9402149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental and clinical assay with ketoconazole in the treatment of Chagas disease.
    Brener Z; Cançado JR; Galvão LM; da Luz ZM; Filardi Lde S; Pereira ME; Santos LM; Cançado CB
    Mem Inst Oswaldo Cruz; 1993; 88(1):149-53. PubMed ID: 8246750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentamidine exerts in vitro and in vivo anti Trypanosoma cruzi activity and inhibits the polyamine transport in Trypanosoma cruzi.
    Díaz MV; Miranda MR; Campos-Estrada C; Reigada C; Maya JD; Pereira CA; López-Muñoz R
    Acta Trop; 2014 Jun; 134():1-9. PubMed ID: 24560964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In search of anti-Trypanosoma cruzi drugs: new leads from a mouse model.
    Kinnamon KE; Steck EA; Hanson WL; Chapman WL
    J Med Chem; 1977 Jun; 20(6):741-4. PubMed ID: 69024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cordycepin (3'-deoxyadenosine) and pentostatin (deoxycoformycin) against Trypanosoma cruzi.
    do Carmo GM; de Sá MF; Grando TH; Gressler LT; Baldissera MD; Monteiro SG; Henker LC; Mendes RE; Stefani LM; Da Silva AS
    Exp Parasitol; 2019 Apr; 199():47-51. PubMed ID: 30825499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas' disease and enhances the efficacy of nifurtimox.
    Faúndez M; López-Muñoz R; Torres G; Morello A; Ferreira J; Kemmerling U; Orellana M; Maya JD
    Antimicrob Agents Chemother; 2008 May; 52(5):1837-9. PubMed ID: 18332173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repositioning FDA-Approved Drug Against Chagas Disease and Cutaneous Leishmaniosis by Structure-Based Virtual Screening.
    Juarez-Saldivar A; Gómez-Escobedo R; Corral-Ruiz G; Chacón-Vargas KF; Horta-Montaño V; Sanchez-Torres L; Vazquez-Jimenez LK; Nogueda-Torres B; Rivera G
    Arch Med Res; 2024 Feb; 55(2):102958. PubMed ID: 38290200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi: efficacy of the 2-substituted, 5-nitroimidazoles, MK-436 and L634,549, in tissue culture and mice.
    Murray PK; Habbersett MC; Meurer RD
    Am J Trop Med Hyg; 1983 Nov; 32(6):1242-50. PubMed ID: 6418014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease.
    Araújo MS; Martins-Filho OA; Pereira ME; Brener Z
    J Antimicrob Chemother; 2000 Jun; 45(6):819-24. PubMed ID: 10837436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb/c mouse model.
    Olmo F; Guardia JJ; Marin C; Messouri I; Rosales MJ; Urbanová K; Chayboun I; Chahboun R; Alvarez-Manzaneda EJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Jan; 89():683-90. PubMed ID: 25462275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-(substituted)benzyl-5-aminoimidazole-4-carboxamides are potent orally active inhibitors of Trypanosoma cruzi in mice.
    Chabala JC; Waits VB; Ikeler T; Patchett AA; Payne L; Peterson LH; Reamer RA; Hoogsteen K; Wyvratt M; Hanson WL
    Experientia; 1991 Jan; 47(1):51-3. PubMed ID: 1900244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cure of short- and long-term experimental Chagas' disease using D0870.
    Urbina JA; Payares G; Molina J; Sanoja C; Liendo A; Lazardi K; Piras MM; Piras R; Perez N; Wincker P; Ryley JF
    Science; 1996 Aug; 273(5277):969-71. PubMed ID: 8688084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease.
    Filardi LS; Brener Z
    Trans R Soc Trop Med Hyg; 1987; 81(5):755-9. PubMed ID: 3130683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantiomers of nifurtimox do not exhibit stereoselective anti-Trypanosoma cruzi activity, toxicity, or pharmacokinetic properties.
    Moraes CB; White KL; Braillard S; Perez C; Goo J; Gaspar L; Shackleford DM; Cordeiro-da-Silva A; Thompson RC; Freitas-Junior L; Charman SA; Chatelain E
    Antimicrob Agents Chemother; 2015; 59(6):3645-7. PubMed ID: 25845874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
    Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi: 4-aminopyrazolopyrimidine in the treatment of experimental Chagas' disease.
    Avila JL; Avila A; Muñoz E; Monzón H
    Exp Parasitol; 1983 Oct; 56(2):236-40. PubMed ID: 6413238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketoconazole protects against infection with Trypanosoma cruzi in a murine model.
    McCabe RE; Araujo FG; Remington JS
    Am J Trop Med Hyg; 1983 Sep; 32(5):960-2. PubMed ID: 6312824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo investigation of the efficacy of arylimidamide DB1831 and its mesylated salt form--DB1965--against Trypanosoma cruzi infection.
    da Silva CF; Batista Dda G; Oliveira GM; de Souza EM; Hammer ER; da Silva PB; Daliry A; Araujo JS; Britto C; Rodrigues AC; Liu Z; Farahat AA; Kumar A; Boykin DW; Soeiro Mde N
    PLoS One; 2012; 7(1):e30356. PubMed ID: 22291940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.